(0.78%) 5 122.00 points
(0.20%) 38 364 points
(1.08%) 17 758 points
(0.29%) $83.81
(-3.54%) $1.580
(0.72%) $2 359.40
(1.32%) $27.72
(0.85%) $928.30
(-0.15%) $0.930
(0.00%) $10.95
(-0.20%) $0.798
(0.08%) $92.24
Live Chart Being Loaded With Signals
IRRAS AB (publ), a medical device company, focuses on the delivery of medical solutions to enhance the lives of critically ill patients worldwide. It designs, develops, and commercializes neurocritical care products that transform patient outcomes and addresses complications associated with current treatment methodologies...
Stats | |
---|---|
Today's Volume | 1.45M |
Average Volume | 551 316 |
Market Cap | 181.75M |
EPS | SEK0 ( 2024-02-13 ) |
Next earnings date | ( SEK0 ) 2024-05-15 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | 0.500 |
ATR14 | SEK0.00700 (4.36%) |
Volume Correlation
IRRAS AB (publ) Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
IRRAS AB (publ) Correlation - Currency/Commodity
IRRAS AB (publ) Financials
Annual | 2022 |
Revenue: | SEK40.00M |
Gross Profit: | SEK8.37M (20.91 %) |
EPS: | SEK-0.520 |
FY | 2022 |
Revenue: | SEK40.00M |
Gross Profit: | SEK8.37M (20.91 %) |
EPS: | SEK-0.520 |
FY | 2021 |
Revenue: | SEK22.39M |
Gross Profit: | SEK-27.98M (-124.98 %) |
EPS: | SEK-1.890 |
FY | 2020 |
Revenue: | SEK7.39M |
Gross Profit: | SEK-16.10M (-217.82 %) |
EPS: | SEK-2.46 |
Financial Reports:
No articles found.
IRRAS AB (publ)
IRRAS AB (publ), a medical device company, focuses on the delivery of medical solutions to enhance the lives of critically ill patients worldwide. It designs, develops, and commercializes neurocritical care products that transform patient outcomes and addresses complications associated with current treatment methodologies. The company offers IRRAflow, an irrigating intracranial drainage system that combines controlled drainage, automated irrigation, and integrated monitoring of intracranial pressure (ICP) for the treatment of patients suffering from hemorrhagic strokes and chronic subdural hematoma. It also provides Hummingbird ICP monitoring system comprising Hummingbird ICP Control Module (HICP200) and the related catheters, which include Hummingbird Quad ICP monitoring with drainage (H610), and Hummingbird Solo ICP monitoring (H110); and Hummingbird neuromonitoring products to manage patients suffering from conditions that cause an elevated intracranial pressure, including traumatic brain injury, subarachnoid hemorrhage, and strokes. It markets and sells its products to hospitals through its direct sales force and a network of distribution partners. IRRAS AB (publ) was incorporated in 2011 and is headquartered in Stockholm, Sweden.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators